Retroviral superantigens, superantigen peptides, and methods of use
CA 2175255 A1 · Owner: University Of Florida · Inventors: Johnson, Howard M.; Torres, Barbara A.; Yamamoto, Janet K.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The subject invention concerns novel superantigen proteins and peptides and methods of use of these superantigens. Specifically exemplified are superantigen proteins and peptide antagonists and agonists from mouse mammary tumor virus feline immunodeficiency, virus and human immunodeficiency virus. The proteins and peptides can also be used to produce purify and detect antibodies that bind to superantigens. These superantigens and their corresponding peptides can be used in both diagnostic and therapeutic protocols.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 31, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 31, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 31, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.